XXXX --outcome of sertraline and escitalopram treatments.

@entity1 @entity4122 @entity146 @entity4 @entity56 @entity74 @entity110
The treatment of dysthymia in itself poses a problem in the everyday @entity146 practice and it can be further hindered when accompanied by pronounced personality traits (which are @entity74 ). Due to its @entity4122 interferes with the @entity1 's quality of life and the ability to function in some segments of everyday life. These interferences enticed our @entity1 to opt for @entity146 treatment. During a three-year period, despite all the efforts made by psychiatrists in this comprehensive and challenging dysthymia treatment (psychotherapy, group psychotherapy, psychopharmacotherapy), the expected outcomes of the treatment did not occur. The @entity1 's goals and expectations included lifestyle change, achieving life satisfaction and mood improvement. The @entity1 was refusing suggested psychopharmaca until confronted, in psychotherapy, with the fact that she is the one prolonging her own helplessness and directing her passive agression at the members of the group. In the end the patent agreed to take psychopharmaca. Therefore, sertraline was introduced in the treatment, but the @entity1 experienced a severe @entity56 (Qiuncke's @entity4 ). After four months the second attempt was made and escitaloptam was introduced, which resulted in @entity110 . Due to these @entity56 to antidepressants, the @entity1 decided not to pursue the psychopharmacological treatment.
